HK1142631A1 - Anti-tumor drug, medicament, composition, and use thereof - Google Patents
Anti-tumor drug, medicament, composition, and use thereofInfo
- Publication number
- HK1142631A1 HK1142631A1 HK10109169.4A HK10109169A HK1142631A1 HK 1142631 A1 HK1142631 A1 HK 1142631A1 HK 10109169 A HK10109169 A HK 10109169A HK 1142631 A1 HK1142631 A1 HK 1142631A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicament
- composition
- tumor drug
- tumor
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20070108349 EP1992694A1 (en) | 2007-05-16 | 2007-05-16 | Anti-tumor drug, medicament, composition, and use thereof |
US11/798,685 US7906621B2 (en) | 2007-05-16 | 2007-05-16 | Anti-tumor drug, medicament, composition, and use thereof |
PCT/EP2008/056075 WO2008138994A1 (en) | 2007-05-16 | 2008-05-16 | Anti-tumor drug, medicament, composition, and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1142631A1 true HK1142631A1 (en) | 2010-12-10 |
Family
ID=39734168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10109169.4A HK1142631A1 (en) | 2007-05-16 | 2010-09-24 | Anti-tumor drug, medicament, composition, and use thereof |
Country Status (9)
Country | Link |
---|---|
US (2) | US8742067B2 (xx) |
EP (1) | EP2158317B1 (xx) |
JP (1) | JP5597534B2 (xx) |
CN (1) | CN101688205B (xx) |
AU (1) | AU2008249961B2 (xx) |
CA (1) | CA2685551C (xx) |
ES (1) | ES2674710T3 (xx) |
HK (1) | HK1142631A1 (xx) |
WO (1) | WO2008138994A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2907823A1 (en) * | 2014-02-14 | 2015-08-19 | Gene Signal International SA | Polypeptide fragments of 168A-T2 and compositions comprising them for use in treating cancer |
US9539305B1 (en) | 2014-03-14 | 2017-01-10 | Fleurir Abx Llc | Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747660A (en) | 1995-11-06 | 1998-05-05 | The University Of Colorado | Nucleic acid encoding prostaglandin F2α receptor regulatory protein |
CA2270875A1 (en) | 1996-11-15 | 1998-05-22 | Cedars-Sinai Medical Center | Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
CA2295303A1 (en) | 1997-06-27 | 1999-01-07 | Human Genome Sciences Inc. | Human nk-3 related prostate specific gene-1 |
US7034132B2 (en) * | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
FR2798674B1 (fr) | 1999-09-21 | 2004-01-30 | Mahmood Salman Al | Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques |
WO2001060860A2 (en) | 2000-02-17 | 2001-08-23 | Millennium Predictive Medicine, Inc. | Genes differentially expressed in human prostate cancer and their use |
US7092985B2 (en) * | 2000-03-30 | 2006-08-15 | United Devices, Inc. | Method of managing workloads and associated distributed processing system |
AU2001274888A1 (en) * | 2000-05-19 | 2001-12-03 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
AU2002232707A1 (en) | 2000-10-27 | 2002-05-06 | Incyte Genomics, Inc. | Transmembrane proteins |
US20020137081A1 (en) | 2001-01-08 | 2002-09-26 | Olga Bandman | Genes differentially expressed in vascular tissue activation |
US6743619B1 (en) * | 2001-01-30 | 2004-06-01 | Nuvelo | Nucleic acids and polypeptides |
WO2002099116A2 (en) | 2001-06-04 | 2002-12-12 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
US7803915B2 (en) * | 2001-06-20 | 2010-09-28 | Genentech, Inc. | Antibody compositions for the diagnosis and treatment of tumor |
CA2633413C (en) * | 2001-06-20 | 2012-08-21 | Genentech, Inc. | Antibodies against tumor-associated antigenic target (tat) polypeptides |
FR2836687A1 (fr) | 2002-03-04 | 2003-09-05 | Gene Signal | Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications |
FR2837391B1 (fr) * | 2002-03-22 | 2007-04-20 | Gene Signal | Genes regulateurs de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications |
US7803906B2 (en) * | 2002-03-22 | 2010-09-28 | Gene Signal International Sa | Composition comprising an angiogenesis related protein |
AU2003279084A1 (en) | 2002-09-25 | 2004-04-19 | Genentech, Inc. | Novel compositions and methods for the treatment of psoriasis |
CA2500715A1 (en) * | 2002-10-03 | 2004-04-15 | Epimmune, Inc. | Hla binding peptides and their uses |
-
2008
- 2008-05-16 ES ES08759707.6T patent/ES2674710T3/es active Active
- 2008-05-16 JP JP2010507938A patent/JP5597534B2/ja not_active Expired - Fee Related
- 2008-05-16 EP EP08759707.6A patent/EP2158317B1/en not_active Not-in-force
- 2008-05-16 CN CN2008800159044A patent/CN101688205B/zh not_active Expired - Fee Related
- 2008-05-16 AU AU2008249961A patent/AU2008249961B2/en not_active Ceased
- 2008-05-16 CA CA2685551A patent/CA2685551C/en not_active Expired - Fee Related
- 2008-05-16 US US12/600,329 patent/US8742067B2/en not_active Expired - Fee Related
- 2008-05-16 WO PCT/EP2008/056075 patent/WO2008138994A1/en active Application Filing
-
2010
- 2010-09-24 HK HK10109169.4A patent/HK1142631A1/xx not_active IP Right Cessation
-
2014
- 2014-01-17 US US14/157,753 patent/US9539306B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2158317A1 (en) | 2010-03-03 |
US20140134276A1 (en) | 2014-05-15 |
US9539306B2 (en) | 2017-01-10 |
JP2010526549A (ja) | 2010-08-05 |
US8742067B2 (en) | 2014-06-03 |
EP2158317B1 (en) | 2018-03-28 |
CA2685551A1 (en) | 2008-11-20 |
CA2685551C (en) | 2016-11-29 |
AU2008249961B2 (en) | 2017-02-02 |
US20100151051A1 (en) | 2010-06-17 |
ES2674710T3 (es) | 2018-07-03 |
AU2008249961A1 (en) | 2008-11-20 |
CN101688205B (zh) | 2013-07-24 |
CN101688205A (zh) | 2010-03-31 |
WO2008138994A1 (en) | 2008-11-20 |
JP5597534B2 (ja) | 2014-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275854A (en) | Pharmaceutical composition and its administration | |
ZA201000185B (en) | 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative | |
IL206952A (en) | History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines | |
IL202376A (en) | History of pyridazinone, drugs and their kit containing and use | |
IL198911A0 (en) | Drug delivery | |
EP2361081A4 (en) | MULTI-PARALLEL INTRA-ORAL DOSAGE FORM AND USE THEREOF | |
EP1981527A4 (en) | THERMALLY TARGET DELIVERY OF DRUGS SUCH AS DOXORUBICIN | |
GB0803072D0 (en) | Solid pharmaceutical and vaccien dose | |
EP2157093A4 (en) | HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE | |
IL204442A (en) | Inhibitors of atpase-0fif, medicinal preparations containing them and their use | |
EP2219725A4 (en) | CUFFS FOR ACTIVE INJECTION | |
IL209421A (en) | Kionoxalindone derivatives, medicines containing them and their use | |
HK1159108A1 (en) | Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof | |
EP2199402A4 (en) | CYCLOASTRAGENOL MONOGLYCOSIDE, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF | |
IL195245A0 (en) | Substituted prolinamides, production thereof and their use as drugs | |
EP2010162A4 (en) | COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT | |
ZA201002307B (en) | Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof | |
EP2208732A4 (en) | DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
ZA201000187B (en) | 17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative | |
TWI366566B (en) | Tricyclic n-heteroarylcarboxamide derivatives, preparation thereof and therapeutic use thereof | |
SI2220047T1 (sl) | Derivati kinolina, farmacevtski sestavki, ki jih vsebujejo in njihova uporaba | |
HK1142631A1 (en) | Anti-tumor drug, medicament, composition, and use thereof | |
IL202474A0 (en) | 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof | |
ZA201000186B (en) | 17b-cyano-19-androst-4-ene derivative,use thereof and medicaments containing said derivative | |
IL191892A0 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200518 |